Humana
Humana Inc. (NYSE:HUM) shares experienced a sharp sell-off this week after the health insurance giant issued a surprisingly conservative financial outlook for 2026. The company warned investors that a massive $3.5 billion net headwind stemming from a decline in Medicare Advantage (MA) Star Ratings would severely compress margins,
CVS
In a pivotal earnings report delivered on February 10, 2026, CVS Health (NYSE: CVS) showcased a complex narrative of financial resilience and operational headwinds. While the healthcare giant posted record-breaking revenue of $402.1 billion for the full year 2025, surpassing Wall Street expectations, its stock dipped nearly 2.5%
Molina Healthcare
The managed care sector was sent into a tailspin on Friday as Molina Healthcare (NYSE: MOH) saw its market capitalization evaporate in a historic sell-off. Shares of the Long Beach-based insurer plummeted 28% to $127.16 after the company issued a 2026 earnings forecast that was not just a miss,
UnitedHealth
In a historic blow to the managed care sector, UnitedHealth Group (NYSE: UNH) saw its stock price plunge nearly 20% on Tuesday, marking its worst single-day performance in over three decades. The massive selloff, which erased approximately $80 billion in market value, was triggered by a surprisingly lean 2027 Advance
Medicare Advantage
The healthcare sector was rocked this week as the Centers for Medicare & Medicaid Services (CMS) released its highly anticipated 2027 Advance Notice, proposing a base payment rate increase that fell staggeringly short of industry expectations. The announcement has sent major insurers into a tailspin, erasing approximately $80 billion in
UnitedHealth
The Dow Jones Industrial Average faced a significant headwind today, as shares of UnitedHealth Group (NYSE: UNH) experienced their worst single-day sell-off in over three decades. The collapse, which wiped out approximately $60 billion in market value, followed the Trump administration’s proposal of a nearly flat payment rate for
UnitedHealth Group
As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary barometer for the multi-trillion-dollar U.S. medical sector. On January 12, 2026, the company issued a critical
Digital Health
October 9, 2025 - Duos, a digital health company dedicated to empowering older adults to live independently, today announced a monumental $130 million strategic growth equity investment. This substantial funding round, spearheaded by FTV Capital with additional participation from early institutional investor Forerunner Ventures, marks a pivotal moment for the
UnitedHealth
New York, NY – October 3, 2025 – While market reports today, October 3, 2025, show UnitedHealth Group (NYSE: UNH) as a top performer in the Dow Jones Industrial Average, with shares gaining approximately 1.5% and extending a five-day winning streak, a closer examination reveals a more complex narrative. Despite this
Humana
Louisville, KY – October 3, 2025 – Humana Inc. (NYSE: HUM) witnessed a significant surge in its stock price today, jumping an impressive 11.9% in early trading. This substantial gain has positioned the managed care giant as a top performer in the financial markets, reflecting robust investor confidence and potentially signaling
UnitedHealth Group
UnitedHealth Group (NYSE: UNH), the nation's largest health insurer, delivered a disappointing second-quarter earnings report for 2025, sending tremors throughout the financial markets and the broader healthcare sector. The company reported adjusted earnings per share (EPS) of $4.08, significantly missing analyst estimates that ranged from $4.45
UnitedHealth Group
UnitedHealth Group (NYSE: UNH), a titan in the U.S. healthcare industry, is grappling with a formidable array of financial and operational challenges that are poised to exert immediate and substantial downward pressure on its Q3 2025 Earnings Per Share (EPS) estimates. A confluence of escalating high-acuity care costs, unfavorable